Fundraising Fox

Optimeos Life Sciences

Princeton, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

RK
Robert K. Prud'homme, PhDFounder
SH
Shahram Hejazi, PhDExecutive

Board

BD
Benjamin DoranzBoard director
JS
Jason Smith, PhDBoard director

Investors · 1

Hatch BioFundreported · 2 sourcesDoylestown

Reported raises · per SEC filings

Form D private placements

$4.4M disclosed across 4 rounds · 2020–2026

▶$1MraisedJun 2026 · 1 investors · Biotechnology
Rule 506(b)
Hatch BioFund Invests in Gene Delivery Startup Optimeos - MyChesComychesco.com · Jul 2026Optimeos Secures Funding for Gene Therapy Platformallsci.com · Jun 2026
Officers, directors & promoters on the filing
  • Jason SmithDirector
  • Shahram HejaziExecutive Officer, Director
  • Robert K Prud'hommeDirector
  • Benjamin DoranzDirector
Offering amount
$2M
Amount sold
$1M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedNov 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin DoranzDirector
  • Shahram Hejazi, PhDExecutive Officer, Director
  • Jason Smith, PhDDirector
  • Robert K. Prud'homme, PhDDirector
Offering amount
$5M
Amount sold
$2.9M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$175KraisedJun 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason Smith, PhDDirector
  • Robert K Prud'homme, PhDDirector
  • Shahram Hejazi, PhDExecutive Officer, Director
Offering amount
$300K
Amount sold
$175K
First sale
May 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$270KraisedAug 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert Prud'homme, PhDDirector
  • Jason Smith, PhDDirector
  • Shahram Hejazi, PhDExecutive Officer, Director
Offering amount
$400K
Amount sold
$270K
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Hatch BioFund Invests in Gene Delivery Startup Optimeos - MyChesComychesco.com · Jul 2026Optimeos Secures Funding for Gene Therapy Platformallsci.com · Jun 2026Hatch BioFund Invests in Optimeos Life Sciences to Advance Nanoparticle Drug Delivery Platform | citybizcitybiz.co · Jun 2026Optimeos Life Sciences Receives Investment From Hatch BioFundfinsmes.com · Jun 2026

Frequently asked questions

Who founded Optimeos Life Sciences?
Optimeos Life Sciences was founded by Robert K. Prud'homme, PhD.
Who are Optimeos Life Sciences's investors?
Optimeos Life Sciences's investors include Hatch BioFund.
How much funding has Optimeos Life Sciences raised?
Optimeos Life Sciences has disclosed $4.4M raised across 4 rounds.
Where is Optimeos Life Sciences headquartered?
Optimeos Life Sciences is headquartered in Princeton, US.